Would-be controls sought to be applied to the U.S. Department of Veterans Affairs underscore the growing degree of regulatory scrutiny being faced by medical actors across the country. As we have noted in some past blog posts, that scrutiny is always intense, with the medical realm being perhaps the most closely overseen industry in the…
Health care “is complicated,” stresses a recent New York Times article. And, notes that piece, a potential new industry player might soon be coming to grips with just how utterly complex the hoops and hurdles relevant to that huge chunk of the economy can be. Notwithstanding the regulatory exactions — authored by local, state and…
A recent study has shown that several states have expanded or enhanced their Medicaid benefits this year, with several planning to do so next year. The increased benefits were primarily for mental health treatment and substance abuse. Some of the other treatments that saw expanded benefits include telemedicine, dental care, oral contraceptives, and cancer screenings….
There is a strong reason why a New York doctor or physician’s assistant might want to turn immediately for help to a proven doctors’ rights law firm following receipt of an adverse communication — indeed, virtually any communication — from the New York Office of Professional Medical Conduct (OPMC). In fact, there are lots of…
Daniels, Porco & Lusardi, LLP, is a New York health care law firm that traces its roots back decades and has collective on-point experience over relevant client matters that spans well more than a century. As such, the firm’s attorneys candidly know a thing or two about the close regulatory scrutiny that health care-related businesses…
A firm of Johnson & Johnson’s stature — and, frankly, that makes for a decidedly short list of players in the pantheon of global companies — knows all about stark business risks and attendant downsides. In J&J’s case, company-directed lawsuits are a recurrent reality, especially given Johnson & Johnson’s huge presence in the health care…
The question is simple and eminently straightforward, to wit: Should nursing home administrators in New York and across the country be able to require prospective patients to agree to mandatory arbitration to resolve disputes as a prerequisite to home admittance, thereby surrendering their right to litigate a contested matter in court before a judge and…
The so-called “Internet of things” (IoT) has been an oft-used phrase in media reports and stories over the past several years. For readers of our New York health care blog at Daniels, Porco & Lusardi, LLP, who might not know much about that concept, it quite simply refers to a device that can be connected…
Carole Faig, a regulatory expert focused on health care matters, concedes the sheer challenges and uncertainty that American medical industry actors routinely face as they seek to promote health and simultaneously prosper. It’s just a given, she says, and something that care principals — “CEOs and other leaders in the health space” — must simply…
The New York State Department of Health made headlines earlier this week when it announced that the cultivation, production and sale of medical marijuana was going to be greatly expanded moving forward with the granting of licenses to five new firms. The move, which brings the number of “registered organizations” licensed to take part in…